DNAGinkgo Bioworks Holdings, Inc.
$11.34-23% 1Y
$11.34
$5.4852 weeks$16.09
Is the price fair?
What DNA's price assumes
Ginkgo Bioworks Holdings, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 2.31× revenue.
2.31
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 0.74
Price / book · as of 2026-Q1
- EV / sales
- 4.20
EV / sales
Details›
- Price / bookas of 2026-Q1
- 0.74
- EV / EBIToperating margin −260%: the multiple describes the denominator
- not meaningful
- EV / salesas of 2026-Q1
- 4.20
- Market capitalisation
- $741M
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.